Is this a joke, look at their price chart.
Plus there seems to be no interest from a partner on fempox. If fempox worked why would they need a partner? Except that their track record selling anything is poor.
The company’s year-on-year decline in earnings was influenced by a weakening in gross margins from 98.62% to -10.17%, as well as issues with cost controls. As a result, operating margins (EBITDA margins) went from 7.68% to -1,244.16% in this time frame. For comparison, gross margins were 50.95% and EBITDA margins were -1,273.26% in the previous period.
With no competition they can't make a profit and they never explained what the problem with Germany was.
Ton of cash better product and larger target market. Plus the CEO isn't a liar.